Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | -98.46%3.32K | -98.46%3.32K | 165.78%215.5K | 165.78%215.5K | 59.47%81.08K | 59.47%81.08K | -94.68%50.85K | -94.68%50.85K | 1,077.14%956.59K | 1,077.14%956.59K |
| -Cash and cash equivalents | -98.46%3.32K | -98.46%3.32K | 165.78%215.5K | 165.78%215.5K | 59.47%81.08K | 59.47%81.08K | -94.68%50.85K | -94.68%50.85K | 1,077.14%956.59K | 1,077.14%956.59K |
| Securities and investments | -24.57%1.76M | -24.57%1.76M | -47.20%2.33M | -47.20%2.33M | -42.84%4.41M | -42.84%4.41M | -51.52%7.71M | -51.52%7.71M | 461.05%15.91M | 461.05%15.91M |
| -Trading securities | -24.57%1.76M | -24.57%1.76M | -47.20%2.33M | -47.20%2.33M | -42.23%4.41M | -42.23%4.41M | -50.99%7.63M | -50.99%7.63M | 512.92%15.57M | 512.92%15.57M |
| -Short term investments | ---- | ---- | ---- | ---- | ---- | ---- | -76.06%81.56K | -76.06%81.56K | 15.27%340.66K | 15.27%340.66K |
| Receivables | ---- | ---- | ---- | ---- | -92.46%19.52K | -92.46%19.52K | 225.96%258.91K | 225.96%258.91K | -82.35%79.43K | -82.35%79.43K |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | 419.52%241.77K | 419.52%241.77K | -88.69%46.54K | -88.69%46.54K |
| -Other receivables | ---- | ---- | ---- | ---- | 13.85%19.52K | 13.85%19.52K | -47.87%17.15K | -47.87%17.15K | -15.29%32.89K | -15.29%32.89K |
| Net PPE | 122.15%1.66K | 122.15%1.66K | -34.76%745 | -34.76%745 | -48.42%1.14K | -48.42%1.14K | -44.02%2.21K | -44.02%2.21K | -18.82%3.96K | -18.82%3.96K |
| -Gross PPE | 122.15%1.66K | 122.15%1.66K | -34.76%745 | -34.76%745 | -48.42%1.14K | -48.42%1.14K | -44.02%2.21K | -44.02%2.21K | -18.82%3.96K | -18.82%3.96K |
| Other assets | ---- | ---- | ---- | ---- | 58.75%267.79K | 58.75%267.79K | --168.68K | --168.68K | ---- | ---- |
| Total assets | -30.78%1.76M | -30.78%1.76M | -46.75%2.54M | -46.75%2.54M | -41.68%4.78M | -41.68%4.78M | -51.66%8.19M | -51.66%8.19M | 194.79%16.95M | 194.79%16.95M |
| Liabilities | ||||||||||
| Current debt and capital lease obligation | --12K | --12K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current debt | --12K | --12K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Payables | 26.86%234.38K | 26.86%234.38K | -51.15%184.76K | -51.15%184.76K | 70.71%378.18K | 70.71%378.18K | 11.19%221.54K | 11.19%221.54K | -12.17%199.24K | -12.17%199.24K |
| -Accounts payable | 333.02%76.84K | 333.02%76.84K | -89.26%17.75K | -89.26%17.75K | 275.13%165.24K | 275.13%165.24K | 164.88%44.05K | 164.88%44.05K | -57.99%16.63K | -57.99%16.63K |
| -Dividends payable | 0.00%61.65K | 0.00%61.65K | -0.24%61.65K | -0.24%61.65K | -1.88%61.8K | -1.88%61.8K | -0.51%62.98K | -0.51%62.98K | 0.00%63.31K | 0.00%63.31K |
| -Other payable | -8.99%95.89K | -8.99%95.89K | -30.29%105.36K | -30.29%105.36K | 32.00%151.14K | 32.00%151.14K | -4.02%114.5K | -4.02%114.5K | -3.75%119.3K | -3.75%119.3K |
| Current provisions | 0.00%880.9K | 0.00%880.9K | -0.02%880.9K | -0.02%880.9K | -0.01%881.11K | -0.01%881.11K | -14.55%881.2K | -14.55%881.2K | 296.09%1.03M | 296.09%1.03M |
| Employee benefits | 31.53%140.89K | 31.53%140.89K | 3.61%107.11K | 3.61%107.11K | 11.25%103.39K | 11.25%103.39K | 25.48%92.93K | 25.48%92.93K | 39.12%74.06K | 39.12%74.06K |
| Total liabilities | 8.13%1.27M | 8.13%1.27M | -13.94%1.17M | -13.94%1.17M | 13.97%1.36M | 13.97%1.36M | -8.34%1.2M | -8.34%1.2M | 141.39%1.3M | 141.39%1.3M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M |
| -common stock | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M | 0.00%19.48M |
| Retained earnings | -2.74%-32.95M | -2.74%-32.95M | -7.11%-32.07M | -7.11%-32.07M | -13.59%-29.94M | -13.59%-29.94M | -50.01%-26.36M | -50.01%-26.36M | -0.02%-17.57M | -0.02%-17.57M |
| Gains losses not affecting retained earnings | 0.00%13.96M | 0.00%13.96M | 0.62%13.96M | 0.62%13.96M | 0.00%13.88M | 0.00%13.88M | 1.03%13.88M | 1.03%13.88M | 316.47%13.73M | 316.47%13.73M |
| Total stockholders'equity | -64.08%492.44K | -64.08%492.44K | -59.85%1.37M | -59.85%1.37M | -51.19%3.41M | -51.19%3.41M | -55.27%7M | -55.27%7M | 200.33%15.64M | 200.33%15.64M |
| Total equity | -64.08%492.44K | -64.08%492.44K | -59.85%1.37M | -59.85%1.37M | -51.19%3.41M | -51.19%3.41M | -55.27%7M | -55.27%7M | 200.33%15.64M | 200.33%15.64M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |